Skip to main content
Clinical Trials/2024-515590-10-00
2024-515590-10-00RecruitingPhase 3

Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study.

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau1 site in 1 country150 target enrollmentStarted: July 15, 2024Last updated:
Drugs

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
150
Locations
1
Primary Endpoint
Cumulative live-birth rate: defined as the number of deliveries that result in a live born neonate, expressed per 100 embryo transfers.

Study Overview

Brief Summary

To evaluate the impact of exercise and the Mediterranean diet vs. aspirin, or no intervention, prior to in vitro fertilization, on the cumulative live birth rate.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with primary infertility justifying IVF treatment, who wish to become pregnant, > 18 years of age, candidates for single embryo transfer in day 5, who give written consent when invited to participate in the study protocol

Exclusion Criteria

  • Pregnancy at the moment of inclusion, presence of comorbidities that contraindicate IVF, pregnancy or childbirth, known allergies to any of the interventions to be applied, probability of loss to follow-up, probability of delivery in another hospital or center.
  • Patients with conditions where LDA administration is contraindicated will also be excluded; some of these conditions or comorbidities would also contraindicate IVF. · Allergy to acetylsalicylic acid or any of the other components. · Gastric ulcer, duodenal or recurrent gastric symptoms. · Allergic asthmatic reactions when taking anti-inflammatories, acetylsalicylic acid, other analgesics, as well as the dye tartrazine. · Hemophilia or other blood clotting problems that predispose to bleeding. · Severe kidney and / or liver failure. · Asthmatic crises, with or without nasal polyps, after ingestion of acetylsalicylic acid. · Diagnosis of glucose-6-phosphate dehydrogenase deficiency. · Treatment with oral anticoagulants. · Treatment with anti-inflammatories or other types of drugs that can interact with LDA. · Hypertension treated with diuretics and angiotensin converting enzyme (ACE) inhibitors.

Outcomes

Primary Outcomes

Cumulative live-birth rate: defined as the number of deliveries that result in a live born neonate, expressed per 100 embryo transfers.

Cumulative live-birth rate: defined as the number of deliveries that result in a live born neonate, expressed per 100 embryo transfers.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Hospital/Clinic/Other health care facility
Responsible Party
Principal Investigator
Principal Investigator

UICEC Sant Pau

Scientific

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Study Sites (1)

Loading locations...

Similar Trials